Kazia Therapeutics Limite...

NASDAQ: KZIA · Real-Time Price · USD
7.90
-0.37 (-4.47%)
At close: Aug 15, 2025, 3:59 PM
8.04
1.71%
After-hours: Aug 15, 2025, 04:10 PM EDT

Kazia Therapeutics Cash Flow Statement

Financials in AUD. Fiscal year is July - June.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021 Dec 31, 2020
Net Income
-26.78M -15.7M -20.47M -25.4M -25.01M -15.26M -8.42M -12.95M
Depreciation & Amortization
1.87M 1.87M 1.87M 1.87M 1.87M 1.66M 1.27M 1.08M
Stock-Based Compensation
533K 650.86K 1.16M 1.98M 1.67M 971.99K 636.38K 364.01K
Other Working Capital
-470K -4.23M 584.09K 5.26M 1.76M 7.36M -1.09M -8.43M
Other Non-Cash Items
15.26M 352.79K -1.75M -4.88M -2.7M 5.05M -4.58M -7.41M
Deferred Income Tax
n/a -2.16M -2.3M -1.48M -332.44K 3.85M 1.55M -937.12K
Change in Working Capital
-465K 144.7K 4.03M 6.25M 1.41M -648.42K 1.99M 573.11K
Operating Cash Flow
-9.58M -12.68M -15.16M -20.18M -22.76M -8.23M -9.11M -18.34M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
5.24M 5.24M n/a -782.45K -782.73K -278 n/a n/a
Investing Cash Flow
5.24M n/a 2.12M 6.58M -782.73K 23.48M 25.71M 2.23M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
5.99M 11.87M 12.97M 9.56M 3.73M 4.52M 28.11M 32.01M
Financial Cash Flow
5.99M 11.87M 12.97M 9.56M 3.73M 4.52M 28.1M 32M
Net Cash Flow
n/a -402.58K 425.34K -14.71M -23.54M 3.79M 21.04M 18.48M
Free Cash Flow
-9.58M -12.68M -15.16M -20.18M -22.76M -8.23M -9.11M -18.34M